Cellebrite DI (CLBT) Amortization of Deferred Charges (2022 - 2024)

Cellebrite DI's Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at $1.4 million for Q4 2024.

• On a quarterly basis, Amortization of Deferred Charges rose 547.32% year-over-year to $1.4 million in Q4 2024; TTM through Dec 2024 was $5.3 million, a 22.31% increase from a year earlier, with the FY2024 full-year figure at $5.3 million, up 22.31% from the prior year.
• Amortization of Deferred Charges improved to $1.4 million in Q4 2024 per CLBT's latest filing, from $1.2 million in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $4.7 million in Q4 2022 and bottomed at $224000.0 in Q4 2023.
• The 3-year median for Amortization of Deferred Charges is $1.3 million (2023), against an average of $1.6 million.
• Across the five-year window, Amortization of Deferred Charges plunged 95.2% in 2023 and jumped 547.32% in 2024, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $4.7 million in 2022, then plunged by 95.2% to $224000.0 in 2023, then soared by 547.32% to $1.4 million in 2024.
• Per Business Quant, the three latest CLBT Amortization of Deferred Charges figures stand at $1.4 million (Q4 2024), $1.2 million (Q3 2024), and $1.3 million (Q2 2024).